Sylvia G. Kachalsky
Corporate Officer/Principal chez Molecular Detection, Inc.
Profil
Sylvia G.
Kachalsky was the founder of Agazyme Ltd.
founded in 2007, where she held the title of Chief Executive Officer.
Currently, she is the Director-Process Development & Commercialization at Molecular Detection, Inc. Dr. Kachalsky's former positions include Consultant at NTG Nordic Transport Group A, Azign Bioscience AS, Interpharm Laboratories Ltd., and Serono Corp.
She was also the Head-Neurobiology & Animal Models at Quark Pharmaceuticals, Inc. Dr. Kachalsky holds a doctorate degree from the Weizmann Institute of Science and a graduate degree from The Hebrew University Hadassah Medical School.
Postes actifs de Sylvia G. Kachalsky
| Sociétés | Poste | Début |
|---|---|---|
Molecular Detection, Inc.
 Molecular Detection, Inc. Medical SpecialtiesHealth Technology Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA. | Corporate Officer/Principal | - |
Anciens postes connus de Sylvia G. Kachalsky
| Sociétés | Poste | Fin |
|---|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | - |
Azign Bioscience AS
 Azign Bioscience AS BiotechnologyHealth Technology Part of Atonomics A/S, Azign Bioscience AS is a biotechnology company based in Copenhagen, Denmark. The Danish company provides biotechnology services. Azign Bioscience was acquired by Atonomics A/S from NTG Nordic Transport Group A/S on June 30, 2004. | Corporate Officer/Principal | - |
| Serono Corp. | Corporate Officer/Principal | - |
Interpharm Laboratories Ltd.
 Interpharm Laboratories Ltd. BiotechnologyHealth Technology Part of Merck KGaA, Interpharm Laboratories Ltd. is an Israeli company that develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. The company is based in Rehovot, Israel. The company was founded by Israel Makov. | Corporate Officer/Principal | - |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
Formation de Sylvia G. Kachalsky
| Weizmann Institute of Science | Doctorate Degree |
| The Hebrew University Hadassah Medical School | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| Entreprise privées | 6 |
|---|---|
Agazyme Ltd.
 Agazyme Ltd. BiotechnologyHealth Technology Agazyme Ltd. operates was a biotech company. It was engages in the research and development of alkaline alpha galactosides for food, beverage, and cosmetic industries. The company was founded in 2007 and is headquartered in Tel Aviv, Israel. | Health Technology |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
Interpharm Laboratories Ltd.
Interpharm Laboratories Ltd. BiotechnologyHealth Technology Part of Merck KGaA, Interpharm Laboratories Ltd. is an Israeli company that develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. The company is based in Rehovot, Israel. The company was founded by Israel Makov. | Health Technology |
| Serono Corp. | |
Azign Bioscience AS
Azign Bioscience AS BiotechnologyHealth Technology Part of Atonomics A/S, Azign Bioscience AS is a biotechnology company based in Copenhagen, Denmark. The Danish company provides biotechnology services. Azign Bioscience was acquired by Atonomics A/S from NTG Nordic Transport Group A/S on June 30, 2004. | Health Technology |
Molecular Detection, Inc.
Molecular Detection, Inc. Medical SpecialtiesHealth Technology Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA. | Health Technology |
